ABNORMAL TAU PROTEINS FROM ALZHEIMERS-DISEASE BRAINS - PURIFICATION AND AMINO-ACID-ANALYSIS

被引:0
|
作者
LIU, WK [1 ]
KSIEZAKREDING, H [1 ]
YEN, SH [1 ]
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,F-538,1300 MORRIS PK AVE,BRONX,NY 10461
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abnormal tau proteins (PHF-tau) were isolated from Alzheimer's disease brains by treatment of paired helical filament enriched-fractions with perchloric acid and boiling of the acid precipitable fraction with beta-mercaptoethanol. These proteins were purified further by a second perchloric acid treatment. The purified PHF-tau proteins were soluble in buffers devoid of sodium dodecyl sulfate. However, they were similar to the abnormal tau extracted from paired helical filaments with sodium dodecyl sulfate, also named A68, in molecular mass (68, 64, and 60 kDa), isoelectric point (pI 5.5-6.5), reactivity with anti-tau antibodies, and in requirement for alkaline phosphatase treatment to bind the Tau-1 antibody. Compared to normal tau, the soluble PHF-tau contained 100% more glycine and 35% less lysine residue. The results suggest that besides phosphorylation other types of modification may be involved in differentiating PHF-tau from normal tau.
引用
收藏
页码:21723 / 21727
页数:5
相关论文
共 50 条
  • [21] ALTERATIONS IN THE THE TRANSMEMBRANE POTENTIAL OF SYNAPTOSOMES PREPARED FROM ALZHEIMERS-DISEASE BRAINS
    BLOOM, AS
    BUNCH, B
    LAMERS, L
    NICHOLSON, K
    ANTUONO, PG
    NEUROBIOLOGY OF AGING, 1994, 15 : S13 - S13
  • [22] IMMUNOAFFINITY PURIFICATION OF A4-RELATED PROTEINS FROM ALZHEIMERS-DISEASE BRAIN-TISSUE
    SMITH, MA
    CLARKE, K
    KIDD, M
    LANDON, M
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (02) : 359 - 359
  • [23] PURIFICATION AND AMINO-ACID-ANALYSIS OF CYTOCHROME-C FROM USTILAGO-VIOLACEA
    WILL, OH
    RUDDAT, M
    GARBER, ED
    CURRENT MICROBIOLOGY, 1983, 8 (01) : 23 - 26
  • [24] DEPHOSPHORYLATION OF ABNORMAL SITES OF TAU-FACTOR BY PROTEIN PHOSPHATASES AND ITS IMPLICATION FOR ALZHEIMERS-DISEASE
    ONO, T
    YAMAMOTO, H
    TASHIMA, K
    NAKASHIMA, H
    OKUMURA, E
    YAMADA, K
    HISANAGA, SI
    KISHIMOTO, T
    MIYAKAWA, T
    MIYAMOTO, E
    NEUROCHEMISTRY INTERNATIONAL, 1995, 26 (03) : 205 - 215
  • [25] ISOLATION OF A PHOSPHORYLATED SOLUBLE TAU FRACTION FROM ALZHEIMERS-DISEASE BRAIN
    LEDESMA, MD
    AVILA, J
    CORREAS, I
    NEUROBIOLOGY OF AGING, 1995, 16 (04) : 515 - 522
  • [26] PURIFICATION AND AMINO-ACID-ANALYSIS OF PLASMA ACID STABLE TRYPSIN-INHIBITOR
    MARUYAMA, M
    YAMAMOTO, T
    SUMI, H
    TSUSHIMA, H
    MIHARA, H
    MINAMINO, N
    ENZYME, 1986, 35 (04) : 225 - 231
  • [27] RECEPTOR-MEDIATED ACTIVATION OF G-PROTEINS IS REDUCED IN POSTMORTEM BRAINS FROM ALZHEIMERS-DISEASE PATIENTS
    WANG, HY
    FRIEDMAN, E
    NEUROSCIENCE LETTERS, 1994, 173 (1-2) : 37 - 39
  • [28] AMINO-ACIDS, GLUTATHIONE, AND GLUTATHIONE TRANSFERASE-ACTIVITY IN THE BRAINS OF PATIENTS WITH ALZHEIMERS-DISEASE
    PERRY, TL
    VOON, WY
    BERGERON, C
    HANSEN, S
    JONES, K
    ANNALS OF NEUROLOGY, 1987, 21 (04) : 331 - 336
  • [29] PEPTIDASES ARE AFFECTED DIFFERENTLY IN NEOCORTICAL REGIONS OF BRAINS FROM PATIENTS WITH ALZHEIMERS-DISEASE
    TERWEL, D
    MARKERINK, M
    JOLLES, J
    DEMENTIA, 1992, 3 (02): : 108 - 113
  • [30] COMPARISON OF METHODS FOR ANALYSIS OF CSF PROTEINS IN PATIENTS WITH ALZHEIMERS-DISEASE
    TOWNSEND, LE
    GILROY, J
    LEWITT, P
    WOLFE, DE
    POMARA, N
    WEINTRAUB, J
    REITZ, D
    NEUROCHEMICAL PATHOLOGY, 1987, 6 (03): : 213 - 229